Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 2, 2006, Pages 294-300

  Cai, Lin ^a,d   Mu, Li Na ^e   Lu, Hua ^a,f   Lu, Qing Yi ^b   You, Nai Chieh Yuko ^a   Yu, Shun Zhang ^f   Le, Anh D ^c   Zhao, Jinkou ^g   Zhou, Xue Fu ^h   Marshall, James ⁱ   Heber, David ^b   Zhang, Zuo Feng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d FUJIAN MEDICAL UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

^f Shanghai Pudong CDC   (China)

^g Taixing City Center for Disease Prevention and Control ^*  (China)

^h Taixing City Center for Disease Prevention and Control   (China)

ⁱ ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ISOLEUCINE; PROLINE; SELENIUM;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; DRINKING BEHAVIOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GSTP1 GENE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; TUMOR SUPPRESSOR GENE;

AGED; ALCOHOLISM; CARCINOMA, SQUAMOUS CELL; DIET; DIET SURVEYS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; SELENIUM; SMOKING;

EID: 33644747119     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0680     Document Type: Article

References (57)

1. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 2001;75:123-39.
2. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005;97:94-102.
3. Taylor PR, Greenwald P. Nutritional interventions in cancer prevention. J Clin Oncol 2005;23:333-45.
4. Wojtczak A. Selenium as an anticancerogenic agent. Acta Pol Pharm 2003;60:215-7.
5. Wei WQ, Abnet CC, Qiao YL, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 2004;79:80-5.
6. Zou XN, Taylor PR, Mark SD, et al. Seasonal variation of food consumption and selected nutrient intake in Linxian, a high risk area for esophageal cancer in China. Int J Vitam Nutr Res 2002;72:375-82.
7. Mark SD, Qiao YL, Dawsey SM, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000;92:1753-63.
8. Zhang YH, Kramer TR, Taylor PR, et al. Possible immunologic involvement of antioxidants in cancer prevention. Am J Clin Nutr 1995;62:1477-82S.
9. Taylor PR, Li B, Dawsey SM, et al. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res 1994;54:2029-31s.
10. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey SM, Li B. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995;62:1424-65.
11. Ryan-Harshman M, Aldoori W. The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Can J Diet Pract Res 2005;66:98-102.
12. Kocdor H, Cehreli R, Kocdor MA, et al. Toxicity induced by the chemical carcinogen 7,12-dimethylbenz[a]anthracene and the protective effects of selenium in Wistar rats. J Toxicol Environ Health A 2005;68:693-701.
13. Longtin R. Selenium for prevention: earing your way to better DNA repair? J Natl Cancer Inst 2003;95:98-100.
14. Smith ML, Lancia JK, Mercer TI, Ip C. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res 2004;24:1401-8.
15. Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism, Proc Natl Acad Sci U S A 2002;99:14548-53.
16. Zhou N, Xiao H, Li TK, Nur-E-Kamal, Liu LF. DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem 2003;278:29532-7.
17. Mannervik B, Awasthi YC, Board PG, et al. Nomenclature for human glutathione transferases. Biochem J 1992;282:305-6.
18. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997;272:10004-12.
19. Lee JM, Wu MT, Lee YC, et al. Association of GSTP1 polymorphism and survival for esophageal cancer. Clin Cancer Res 2005;11:4749-53.
20. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev 1998;7:1013-8.
21. Morita S, Yano M, Tsujinaka T, et al. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 1998;79:517-20.
22. Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res 1998;18:2095-9.
23. Lane DP. Cancer. A death in the life of p53. Nature 1993;362:786-7.
24. Bennett WP, Hollstein MC, Metcalf RA, et al. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992;52:6092-7.
25. Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000;89:458-64.
26. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987;7:961-3.
27. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004;13:11-22.
28. Shen H, Solari A, Wang X, et al. p53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 2004;11:1115-20.
29. Lacerda LL, Serrano SV, Mathes A, Rey JA, Bello MJ, Casartelli C. An intronic variant in the Tp53 gene in a Brazilian woman with breast cancer. Cancer Genet Cytogenet 2005;160:160-3.
30. Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 2000;9:113-8.
31. Lu XM, Zhang YM, Lin RY, et al. p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China. World J Gastroenterol 2004;10:2775-8.
32. Santos AM, Sousa H, Catarino R, et al. Tp53 codon 72 polymorphism and risk for cervical cancer in Portugal. Cancer Genet Cytogenet 2005;159:143-7.
33. Mu LN, Lu QY, Yu SZ, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 2005;116:972-83.
34. China CDC. Food nutritient components table. Beijing (China): China People's Medical Publishing House; 2000.
35. Diaz-Cano SJ, Brady SP. DNA extraction from formalin-fixed, paraffin-embedded tissues: protein digestion as a limiting step for retrieval of high-quality DNA. Diagn Mol Pathol 1997;6:342-6.
36. Jaskiewicz K, Marasas WF, Rossouw JE, Van Niekerk FE, Heine Tech EW. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer 1988;62:2635-9.
37. Klein EA. Selenium: epidemiology and basic science. J Urol 2004;171:S50-3.
38. Djavan B, Zlotta A, Schulman C, et al. Chemotherapeutic prevention studies of prostate cancer. J Urol 2004;171:S10-3.
39. Rayman MP. Dietary selenium: time to act. BMJ 1997;314:387-8.
40. Nouarie M, Pourshams A, Kamangar F, et al. Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol 2004;10:2544-6.
41. Chen X, Mikhail SS, Ding YW, Yang G, Bondoc F, Yang CS. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis 2000;21:1531-6.
42. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-4.
43. Clark LC, Combs GF, Jr., Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
44. Burk RF. Selenium, an antioxidant nutrient. Nutr Clin Care 2002;5:75-9.
45. Zimniak P, Nanduri B, Pikula S, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994;224:893-9.
46. Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep 2003;10:1615-23.
47. Casson AG, Zheng Z, Chiasson D, et al. Associations between genetic polymorphisms of phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 2003;27:139-46.
48. van Lieshout EM, Roelofs HM, Dekker S, et al. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999;59:586-9.
49. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 2002;179:175-83.
50. Li X, Dumont P, Della PA, Shetler C, Murphy ME. The codon 47 polymorphism in p53 is functionally significant. J Biol Chem 2005;280:24245-51.
51. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-100.
52. El-Bayoumy K, Sinha R. Molecular chemoprevention by selenium: A genomic approach. Mutat Res 2005;591:224-36. Epub 2005 Aug 15.
53. El-Bayoumy K, Chae YH, Upadhyaya P, Meschter C, Cohen LA, Reddy BS. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res 1992;52:2402-7.
54. Sinha R, El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr Cancer Drug Targets 2004;4:13-28.
55. Kafai MR, Ganji V. Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. J Trace Elem Med Biol 2003;17:13-8.
56. Greenwald P, Milner JA, Anderson DE, McDonald SS. Micronutrients in cancer chemoprevention. Cancer Metastasis Rev 2002;21:217-30.
57. Willett W. Food frequency methods. Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998. p. 74-100.